Safety and effectiveness of dupilumab in the real‐world treatment of atopic dermatitis in Japan: 1‐year interim analysis from a post‐marketing surveillance by Hidehisa Saeki, Hiroyuki Fujita, Katsuhisa Suzuki, Kazuhiko Arima

Connect to this object online.

Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study by Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Connect to this object online.

The differential effects of upadacitinib treatment on skin rashes of four anatomical sites in patients with atopic dermatitis by Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Connect to this object online.

Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan by Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Connect to this object online.

Recurrence or <i>de novo</i>? Intradermal Basal Cell Carcinoma of the Scrotum: A Report of Two Cases by Kaori Yamazaki, Maho Maejima, Hidehisa Saeki, Shin-Ichi Osada

Connect to this object online.

Successful treatment of psoriasis vulgaris with ixekizumab in a patient with concurrent Sjögren's syndrome presenting with dry eye and incomplete SLE by Marina Onda, Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Connect to this object online.

Drug survival rate of dupilumab in Japanese patients with atopic dermatitis by Susumu Ichiyama, Michiko Ito, Toshihiko Hoashi, Naoko Kanda, Hidehisa Saeki

Connect to this object online.

Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database by Celine Miyazaki, Junya Masuda, Phiona I-Ching Tsai, Hidehisa Saeki

Connect to this object online.

Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan by Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Connect to this object online.

Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study by Teppei Hagino, Risa Hamada, Mai Yoshida, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Connect to this object online.

Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis by Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Connect to this object online.

An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic Dermatitis by Hidehisa Saeki, Yukihiro Ohya, Naoko Baba, Tomomi Imamura, Daisuke Yokota, Hidetsugu Tsubouchi

Connect to this object online.

Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis by Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Connect to this object online.

Real‐world treatment patterns of patients with atopic dermatitis in Japan: Analysis of the JMDC Claims Database by Kazumasa Kamei, Hidehisa Saeki, Takanori Tsuchiya, Tomohiro Hirose, Eduardo Campos‐Alberto, Fumihiro Matsumoto, Noritoshi Yoshii, Shinichi Imafuku

Connect to this object online.

Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis by Hidehisa Saeki, Yoko Kataoka, Takafumi Etoh, Norito Katoh, Satoshi Teramukai, Yuki Tajima, Hiroyuki Fujita, Marius Ardeleanu, Kazuhiko Arima

Connect to this object online.

Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan by Celine Miyazaki, Junya Masuda, Mateo Delclaux Rodriguez-Rey, Marta Natalia Stelmaszuk, Jonatan Freilich, Phiona I-Ching Tsai, Hidehisa Saeki

Connect to this object online.

Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: Analysis of the 3-Year Phase 3 Rising Up Study by Norito Katoh, Masanori Ikeda, Yukihiro Ohya, Hiroyuki Murota, Xiaofei Hu, John Liu, Hayato Niiyama, Takuya Sasaki, Eliza M. Raymundo, Hidehisa Saeki

Connect to this object online.

A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moder... by Norito Katoh, MD, PhD, Yukihiro Ohya, MD, PhD, Hiroyuki Murota, MD, PhD, Masanori Ikeda, MD, PhD, Xiaofei Hu, PhD, Kimitoshi Ikeda, PhD, John Liu, MD, MS, Takuya Sasaki, Alvina D. Chu, MD, Henrique D. Teixeira, PhD, MBA, Hidehisa Saeki, MD, PhD

Connect to this object online.